GHO Capital realises significant return with sale of FairJourney Biologics
01 juil. 2024 07h00 HE
|
GHO Capital
GHO Capital realises significant return with sale of FairJourney Biologics Under GHO’s ownership FairJourney Biologics has become an established leader in antibody discovery and development, with...
GHO Capital realises significant return with sale of FairJourney Biologics
01 juil. 2024 02h00 HE
|
GHO Capital
GHO Capital realises significant return with sale of FairJourney Biologics Under GHO’s ownership FairJourney Biologics has become an established leader in antibody discovery and development, with...
Garry Menzel joins GHO Capital as Operating Partner
23 avr. 2024 07h45 HE
|
GHO Capital
Garry Menzel joins GHO Capital as Operating Partner Former CEO of TCR² Therapeutics with significant investment and operating experience to support deal origination and provide best in class services...
Garry Menzel joins GHO Capital as Operating Partner
23 avr. 2024 02h00 HE
|
GHO Capital
Garry Menzel joins GHO Capital as Operating Partner Former CEO of TCR² Therapeutics with significant investment and operating experience to support deal origination and provide best in class services...
Stuart Quin joins GHO Capital as Partner
04 janv. 2024 07h00 HE
|
GHO Capital
Stuart Quin joins GHO Capital as Partner Former CEO of Medica Group Plc and regional CEO of Synlab to support the continued growth of GHO Capital’s portfolio and origination of future investments ...
Stuart Quin joins GHO Capital as Partner
04 janv. 2024 02h00 HE
|
GHO Capital
Stuart Quin joins GHO Capital as Partner Former CEO of Medica Group Plc and regional CEO of Synlab to support the continued growth of GHO Capital’s portfolio and origination of future investments ...
GHO Capital and Partners Group invest in Sterling Pharma Solutions, a leading pharmaceutical development and manufacturing organization
25 mai 2023 04h00 HE
|
GHO Capital
GHO Capital and Partners Group invest in Sterling Pharma Solutions, a leading pharmaceutical development and manufacturing organization Since first partnering with GHO in 2019, Sterling Pharma...
GHO Capital invests in Sapio Sciences, a leading, high growth lab informatics platform company
01 déc. 2022 07h00 HE
|
GHO Capital
GHO Capital invests in Sapio Sciences, a leading, high growth lab informatics platform company Sapio has established a unique, highly scalable, best in class lab informatics platform with multiple...
GHO Capital and The Vistria Group to acquire Alcami, a leading high growth CDMO, from Madison Dearborn Partners and Ampersand Capital Partners
08 nov. 2022 09h01 HE
|
Alcami
GHO Capital and The Vistria Group to acquire Alcami, a leading high growth CDMO, from Madison Dearborn Partners and Ampersand Capital Partners A high growth CDMO with integrated capabilities across...